40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details


臨床試験数 : 25 薬物数 : 50 - (DrugBank : 21) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 114

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04161898
(ClinicalTrials.gov)
February 4, 202012/11/2019A Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (TAK)A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (SELECT-Takayasu)Takayasu Arteritis (TAK)Drug: Upadacitinib;Drug: Placebo for Upadacitinib;Drug: PrednisoloneAbbVieNULLRecruiting18 YearsN/AAll54Phase 3Japan;Korea, Republic of;Turkey